|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 August 2001, Vol. 98, No. 3, pp. 877-879
BRIEF REPORT
Defective expression of the interleukin-2/interleukin-15 receptor
subunit leads to a natural killer cell-deficient form of severe
combined immunodeficiency
Kimberly C. Gilmour,
Hodaka Fujii,
Treena Cranston,
E. Graham Davies,
Christine Kinnon, and
Hubert B. Gaspar
From the Molecular Immunology Unit, Institute of Child
Health, University College London; the Departments of Clinical
Molecular Genetics and Immunology, Great Ormond Street Hospital,
London, United Kingdom; and the Department of Immunology, Graduate
School of Medicine and Faculty of Medicine, University of Tokyo, Japan.
Development of T and natural killer (NK) cells is critically
dependent on cytokine signaling, and defects in cytokine receptor complex subunits have been shown to result in severe combined immunodeficiency (SCID) syndromes in humans and in murine models. An
infant boy had typical clinical features of SCID and was found to lack
NK cells in his peripheral circulation. Molecular analysis did not
reveal abnormalities in his c or JAK-3 genes, and he was
investigated for defects in the interleukin-15 (IL-15) receptor complex
because functional IL-15 signaling is essential for NK cell
development. Expression of the IL-2R/IL-15R chain was
significantly reduced in the patient's peripheral blood mononuclear
cells (PBMCs) by immunoblot, flow cytometry, and Northern blot
analysis. Furthermore, IL-2 stimulation of PBMCs showed only
minimal tyrosine phosphorylation of JAK-3. These data
demonstrate that defects in IL-2R/1L-15R expression can
lead to a unique NK-deficient SCID immunophenotype.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Eidenschenk, E. Jouanguy, A. Alcais, J.-J. Mention, B. Pasquier, I. M. Fleckenstein, A. Puel, L. Gineau, J.-C. Carel, E. Vivier, et al.
Familial NK Cell Deficiency Associated with Impaired IL-2- and IL-15-Dependent Survival of Lymphocytes
J. Immunol.,
December 15, 2006;
177(12):
8835 - 8843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Liu, L. V. Kaer, A. L. Cava, M. Price, D. I. Campagnolo, M. Collins, D. A. Young, T. L. Vollmer, and F.-D. Shi
Autoreactive T Cells Mediate NK Cell Degeneration in Autoimmune Disease
J. Immunol.,
May 1, 2006;
176(9):
5247 - 5254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Grund, D. D. Spyropoulos, D. K. Watson, and R. C. Muise-Helmericks
Interleukins 2 and 15 Regulate Ets1 Expression via ERK1/2 and MNK1 in Human Natural Killer Cells
J. Biol. Chem.,
February 11, 2005;
280(6):
4772 - 4778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Conklyn, C. Andresen, P. Changelian, and E. Kudlacz
The JAK3 inhibitor CP-690550 selectively reduces NK and CD8+ cell numbers in cynomolgus monkey blood following chronic oral dosing
J. Leukoc. Biol.,
December 1, 2004;
76(6):
1248 - 1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Chklovskaia, P. Nowbakht, C. Nissen, A. Gratwohl, M. Bargetzi, and A. Wodnar-Filipowicz
Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand
Blood,
May 15, 2004;
103(10):
3860 - 3868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bernard, C. Picard, V. Cormier-Daire, C. Eidenschenk, G. Pinto, J.-C. Bustamante, E. Jouanguy, D. Teillac-Hamel, V. Colomb, I. Funck-Brentano, et al.
A Novel Developmental and Immunodeficiency Syndrome Associated With Intrauterine Growth Retardation and a Lack of Natural Killer Cells
Pediatrics,
January 1, 2004;
113(1):
136 - 141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Barlic, J. M. Sechler, and P. M. Murphy
IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1
Blood,
November 15, 2003;
102(10):
3494 - 3503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Kalberer, U. Siegler, and A. Wodnar-Filipowicz
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells
Blood,
July 1, 2003;
102(1):
127 - 135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Cooper, J. E. Bush, T. A. Fehniger, J. B. VanDeusen, R. E. Waite, Y. Liu, H. L. Aguila, and M. A. Caligiuri
In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells
Blood,
November 15, 2002;
100(10):
3633 - 3638.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |